VBMSPDKNB9

Viresolve^® Barrier Capsule

Process Development Kit

• Synonim(y): Viresolve^® Barrier Micro Process Development Kit
• Kod UNSPSC: 23151806
• eCl@ss: 32031690

Właściwości

• Materiały: molded polypropylene component(s); polyethersulfone membrane; teal device
• producent / nazwa handlowa: Viresolve^®
• Parametry: 4.1 bar max. inlet pressure (60 psig)
• dilution: (process development studies)
• Wys. × śr.: 3.83 cm (1.51 in.) × 3.07 cm (1.21 in.)
• Wysokość: 3.83 cm (1.51 in.)
• Średnica: 3.07 cm (1.21 in.)
• powierzchnia filtracyjna: 3.3 cm²
• zanieczyszczenia: <0.25 EU/mL USP bacterial endotoxins (LAL test, sample aqueous extraction)
• dopasowywanie: female Luer inlet fitting; male Luer outlet fitting

Opis

Opis ogólny

Device Configuration: Micro

Zastosowanie

Process Development Kit

Inne uwagi

These products are manufactured in a facility which adheres to FDA Good Manufacturing Practices.

Directions for Use

• Organism Retention: Parvovirus
• Mode of Action: Filtration (size exclusion)
• Application: Protein purification
• Intended Use: Viral clearance
• Instructions for Use: Please see the user guide shipped with this product
• Storage Statement: Store at room temperature
• Disposal Statement: Dispose of in accordance with applicable federal, state and local regulations.

Uwaga dotycząca przygotowania

This product was manufactured with materials that meet the criteria for a "non-fiber releasing" filter as defined in 21 CFR 210.3 (b) (6).

Komentarz do analizy

TOC/Conductivity
After a controlled water flush of 40 L/m², samples exhibited less than 500 ppb TOC per USP <64> and less than 1.3 µS/cm per USP <64>.

Informacje prawne

VIRESOLVE is a registered trademark of Merck KGaA, Darmstadt, Germany

Ta strona może zawierać tekst przetłumaczony maszynowo.